-Ritu Aneja Researcher Activity Profile

Research Author Detailed Information 

Ritu Aneja Publication Rate By Year

Ritu Aneja has published 1 paper(s) in 2006, 5 paper(s) in 2007, 4 paper(s) in 2008, for a total of 10 research publications in total.

Ritu R Aneja Author Information

LAST NAME: aneja

FIRST NAME: Ritu

INITIALS: r

AFFILIATION:

Papers

Ritu Aneja's Publication Record

1. p53 and p21 determine the sensitivity of noscapine-induced apoptosis in colon cancer cells. Year Published: 2007
Department of Cell Biology and Division of Digestive Diseases, Emory University School of Medicine, 615 Michael Street, Atlanta, GA 30322, USA.
2. Extracellular heat shock protein-70 induces endotoxin tolerance in THP-1 cells. Year Published: 2006
Department of Critical Care Medicine, University of Pittsburgh School of Medicine and Children's Hospital of Pittsburgh, Pittsburgh, PA 15213, USA. anejar@upmc.edu
3. Promising therapeutic agents for sepsis. Year Published: 2007
Department of Critical Care Medicine, University of Pittsburgh, School of Medicine, Pittsburgh, PA 15261, USA.
4. Nonimmunosuppressive chemotherapy: EM011-treated mice mount normal T-cell responses to an acute lymphocytic choriomeningitis virus infection. Year Published: 2007
Laboratory for Drug Discovery, Design, and Research, Department of Cell Biology, Emory University School of Medicine, Atlanta, GA 30322. raneja@emory.edu.
5. Nonimmunosuppressive chemotherapy: EM011-treated mice mount normal T-cell responses to an acute lymphocytic choriomeningitis virus infection. Year Published: 2007
Laboratory for Drug Discovery, Design, and Research, Department of Cell Biology, Emory University School of Medicine, Atlanta, GA 30322, USA. raneja@emory.edu
6. Recent patents on proteases and kinases as anti-infective agents: a review. Year Published: 2008
Laboratory for Drug Discovery and Research, Department of Cell Biology, Emory University School of Medicine, Atlanta, GA 30322, USA. svangap@emory.edu
7. Recent patents on proteases and kinases as anti-infective agents: a review. Year Published: 2008
Laboratory for Drug Discovery and Research, Department of Cell Biology, Emory University School of Medicine, Atlanta, GA, USA. joshi@cellbio.emory.edu; svangap@emory.edu.
8. Modulation of multidrug resistance in cancer cells by the E3 ubiquitin ligase seven-in-absentia homologue 1. Year Published: 2008
Department of Genetics and Cell Biology, College of Life Sciences, Nankai University, Tianjin 300071, People's Republic of China.
9. Nonimmunosuppressive chemotherapy: EM011-treated mice mount normal T-cell responses to an acute lymphocytic choriomeningitis virus infection. Year Published: 2007
Laboratory for Drug Discovery, Design, and Research, Department of Cell Biology, Emory University School of Medicine, Atlanta, GA 30322, USA. raneja@emory.edu
10. Modulation of multidrug resistance in cancer cells by the E3 ubiquitin ligase seven-in-absentia homologue 1. Year Published: 2008
Department of Genetics and Cell Biology, College of Life Sciences, Nankai University, Tianjin 300071, People's Republic of China.